chr1-20652339-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005216.5(DDOST):c.*40A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.87 in 1,529,674 control chromosomes in the GnomAD database, including 579,708 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.84 ( 53971 hom., cov: 32)
Exomes 𝑓: 0.87 ( 525737 hom. )
Consequence
DDOST
NM_005216.5 3_prime_UTR
NM_005216.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.10
Genes affected
DDOST (HGNC:2728): (dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit) This gene encodes a component of the oligosaccharyltransferase complex which catalyzes the transfer of high-mannose oligosaccharides to asparagine residues on nascent polypeptides in the lumen of the rough endoplasmic reticulum. The protein complex co-purifies with ribosomes. The product of this gene is also implicated in the processing of advanced glycation endproducts (AGEs), which form from non-enzymatic reactions between sugars and proteins or lipids and are associated with aging and hyperglycemia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-20652339-T-C is Benign according to our data. Variant chr1-20652339-T-C is described in ClinVar as [Benign]. Clinvar id is 295057.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.873 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDOST | NM_005216.5 | c.*40A>G | 3_prime_UTR_variant | 11/11 | ENST00000602624.7 | NP_005207.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDOST | ENST00000602624.7 | c.*40A>G | 3_prime_UTR_variant | 11/11 | 1 | NM_005216.5 | ENSP00000473655 | P1 | ||
DDOST | ENST00000415136.6 | c.*40A>G | 3_prime_UTR_variant | 11/11 | 1 | ENSP00000399457 |
Frequencies
GnomAD3 genomes AF: 0.840 AC: 127779AN: 152052Hom.: 53937 Cov.: 32
GnomAD3 genomes
AF:
AC:
127779
AN:
152052
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.862 AC: 145250AN: 168494Hom.: 62788 AF XY: 0.867 AC XY: 78655AN XY: 90736
GnomAD3 exomes
AF:
AC:
145250
AN:
168494
Hom.:
AF XY:
AC XY:
78655
AN XY:
90736
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.873 AC: 1202625AN: 1377504Hom.: 525737 Cov.: 30 AF XY: 0.874 AC XY: 592512AN XY: 678126
GnomAD4 exome
AF:
AC:
1202625
AN:
1377504
Hom.:
Cov.:
30
AF XY:
AC XY:
592512
AN XY:
678126
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.840 AC: 127870AN: 152170Hom.: 53971 Cov.: 32 AF XY: 0.842 AC XY: 62626AN XY: 74410
GnomAD4 genome
AF:
AC:
127870
AN:
152170
Hom.:
Cov.:
32
AF XY:
AC XY:
62626
AN XY:
74410
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2916
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 23, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Congenital disorder of glycosylation type Ir Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Congenital disorder of glycosylation Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Parkinson Disease, Recessive Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at